IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — PGEN

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.020.010.010.010.010.020.010.020.010.020.010.010.040.040.040.040.03
Short-term Investments0.020.050.110.050.070.000.010.030.060.070.090.060.070.070.070.080.08
Accounts Receivable0.070.030.000.000.000.000.000.000.000.000.000.000.000.020.020.030.02
Total Current Assets0.130.100.130.060.080.030.020.050.090.110.140.160.160.150.150.160.14
Property, Plant & Equipment0.010.010.010.010.010.010.010.010.010.010.010.010.010.030.030.030.03
Goodwill0.020.020.020.020.020.020.020.030.040.040.040.040.040.050.050.050.05
Intangible Assets0.000.000.000.000.000.000.010.040.040.040.040.040.050.050.060.060.06
Total Non-current Assets*0.040.040.040.040.040.050.050.090.100.100.100.100.160.180.220.250.26
Total Assets0.170.140.170.100.130.080.070.130.190.210.240.260.320.340.380.400.41
Accounts Payable0.010.000.010.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Short-term Debt----------------0.000.000.01------------
Total Current Liabilities0.030.020.030.020.020.020.020.030.030.030.050.100.030.030.030.030.03
Long-term Debt0.090.090.09----------------0.080.200.200.180.180.17
Total Non-current Liabilities*0.100.100.100.080.090.010.010.010.010.010.010.010.240.240.220.210.21
Total Liabilities0.130.120.130.110.110.030.030.040.040.040.060.120.270.260.250.240.23
Retained Earnings(2.33)(2.35)(2.32)(2.17)(2.14)(2.07)(2.05)(1.99)(1.93)(1.91)(1.89)(1.85)(1.93)(1.92)(1.89)(1.86)(1.84)
Total Stockholder Equity0.040.020.04(0.04)(0.01)0.060.040.100.150.170.180.140.060.070.130.160.17

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue54.9823.25------1.34----1.77----21.531.771.85(24.74)16.722.9132.0224.2221.56
Research & Development7.285.64------------------------------------
Selling, General & Admin22.2521.05------------------------------------
Total Operating Expenses32.3429.25------------------------------------
Operating Income22.64(5.99)------------------------------------
Pretax Income20.07(7.93)--------(19.81)(23.97)(60.48)(23.77)(33.39)(19.80)(20.38)(22.79)(26.81)(7.69)(26.15)(19.31)(25.02)(29.88)
Tax Provision0.000.000.000.000.000.00(0.09)0.01(1.69)(0.03)(0.33)(0.01)(0.06)(0.05)0.01----------
Net Income20.07(7.93)(23.50)(146.34)(26.64)(54.15)(19.73)(23.98)(58.79)(23.74)(33.06)(19.80)(20.32)(22.73)(22.18)87.38(17.64)(19.25)(25.03)(29.76)
Basic EPS0.06(0.02)(0.04)(1.06)(0.09)(0.18)(0.05)(0.09)(0.23)(0.10)(0.13)(0.08)(0.08)(0.10)(0.11)0.44(0.09)(0.10)(0.13)(0.15)
Diluted EPS0.05(0.02)(0.04)(1.06)(0.09)(0.18)(0.05)(0.09)(0.23)(0.10)(0.13)(0.08)(0.08)(0.10)(0.11)0.44(0.09)(0.10)(0.13)(0.15)

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(17.81)(43.83)(23.46)(29.07)(18.98)(16.32)(8.24)(22.73)(23.11)(14.09)(15.77)(17.01)(15.77)(18.39)(15.40)(23.81)(7.05)(18.78)(14.59)(17.02)
Capital Expenditures0.390.260.020.390.970.621.030.882.324.351.050.240.100.150.051.571.721.582.772.27
Free Cash Flow*(18.20)(44.08)(23.48)(29.46)(19.94)(16.95)(9.27)(23.61)(25.43)(18.44)(16.81)(17.24)(15.87)(18.54)(15.45)(25.39)(8.77)(20.36)(17.36)(19.29)
Investing Cash Flow26.6920.9739.87(63.39)28.44(6.46)(65.37)5.6514.9624.0513.2910.5323.50(50.41)11.42181.8616.5716.5715.9322.01
Financing Cash Flow(0.03)0.11(0.51)93.01(1.77)(0.68)78.4032.130.050.000.000.00(14.58)44.17(39.28)(115.73)(0.11)(0.16)(0.11)0.23

* Derived from reported values